Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care (Q33383626)

26 July 2017

Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care (English)

1 reference

26 July 2017

Peter Bramlage

1

0 references

author name string

Eleonore Schönrock

series ordinal

2

1 reference

PubMed ID

19000308

26 July 2017

Peter Odoj

series ordinal

3

1 reference

26 July 2017

10 November 2008

1 reference

BMC Cardiovascular Disorders

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

30

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

start time

10 November 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2261-8-30

0 references

cites work

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Global burden of hypertension: analysis of worldwide data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Primary prevention of cardiovascular disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Selected major risk factors and global and regional burden of disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Randomized, controlled trials, observational studies, and the hierarchy of research designs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

High prevalence and poor control of hypertension in primary care: cross-sectional study.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Incident diabetes in clinical trials of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16,600 patients in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-8-30

Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with Candesartan/HCTZ

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2588554

Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19000308

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19000308

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2261-8-30

1 reference

PubMed ID

19000308

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference

PubMed ID

19000308